180 related articles for article (PubMed ID: 19574601)
1. Alvimopan for postoperative ileus.
Bream-Rouwenhorst HR; Cantrell MA
Am J Health Syst Pharm; 2009 Jul; 66(14):1267-77. PubMed ID: 19574601
[TBL] [Abstract][Full Text] [Related]
2. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
[TBL] [Abstract][Full Text] [Related]
3. Alvimopan for the management of postoperative ileus.
Leslie JB
Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.
Delaney CP; Weese JL; Hyman NH; Bauer J; Techner L; Gabriel K; Du W; Schmidt WK; Wallin BA;
Dis Colon Rectum; 2005 Jun; 48(6):1114-25; discussion 1125-6; author reply 1127-9. PubMed ID: 15906123
[TBL] [Abstract][Full Text] [Related]
5. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
[TBL] [Abstract][Full Text] [Related]
6. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.
Wolff BG; Weese JL; Ludwig KA; Delaney CP; Stamos MJ; Michelassi F; Du W; Techner L
J Am Coll Surg; 2007 Apr; 204(4):609-16. PubMed ID: 17382220
[TBL] [Abstract][Full Text] [Related]
7. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
Viscusi ER; Goldstein S; Witkowski T; Andonakakis A; Jan R; Gabriel K; Du W; Techner L; Wallin B
Surg Endosc; 2006 Jan; 20(1):64-70. PubMed ID: 16333556
[TBL] [Abstract][Full Text] [Related]
8. The use of alvimopan for postoperative ileus in small and large bowel resections.
Brady JT; Dosokey EM; Crawshaw BP; Steele SR; Delaney CP
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1351-8. PubMed ID: 26488223
[TBL] [Abstract][Full Text] [Related]
9. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis.
Ludwig K; Viscusi ER; Wolff BG; Delaney CP; Senagore A; Techner L
World J Surg; 2010 Sep; 34(9):2185-90. PubMed ID: 20526599
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.
Ludwig K; Enker WE; Delaney CP; Wolff BG; Du W; Fort JG; Cherubini M; Cucinotta J; Techner L
Arch Surg; 2008 Nov; 143(11):1098-105. PubMed ID: 19015469
[TBL] [Abstract][Full Text] [Related]
11. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
12. Alvimopan for post-operative ileus: What we should know?
Nair A
Acta Anaesthesiol Taiwan; 2016 Sep; 54(3):97-98. PubMed ID: 27825721
[TBL] [Abstract][Full Text] [Related]
13. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
14. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
[TBL] [Abstract][Full Text] [Related]
15. Alvimopan.
Curran MP; Robins GW; Scott LJ; Perry CM
Drugs; 2008; 68(14):2011-9. PubMed ID: 18778122
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus.
Tan EK; Cornish J; Darzi AW; Tekkis PP
Aliment Pharmacol Ther; 2007 Jan; 25(1):47-57. PubMed ID: 17042776
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
Kraft MD
Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
[TBL] [Abstract][Full Text] [Related]
18. Cost and efficacy examination of alvimopan for the prevention of postoperative ileus.
Nemeth ZH; Bogdanovski DA; Paglinco SR; Barratt-Stopper P; Rolandelli RH
J Investig Med; 2017 Jun; 65(5):949-952. PubMed ID: 28566386
[TBL] [Abstract][Full Text] [Related]
19. Alvimopan: a peripherally acting mu-opioid receptor antagonist.
Leslie JB
Drugs Today (Barc); 2007 Sep; 43(9):611-25. PubMed ID: 17940638
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.
Büchler MW; Seiler CM; Monson JR; Flamant Y; Thompson-Fawcett MW; Byrne MM; Mortensen ER; Altman JF; Williamson R
Aliment Pharmacol Ther; 2008 Aug; 28(3):312-25. PubMed ID: 19086236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
